BioHarvest Sciences Inc.’s Growth Strategy Progress Update; Zoom Video Conference – September 16, 2020 @ 2:00pm EST
BioHarvest Sciences Inc. (CSE: BHSC) (the “Company”, “BioHarvest”) invites its Shareholders and the General Public to join a Live Zoom Video Conference (“Webinar”) on Wednesday, September 16th, 2020 at 2:00 PM Eastern Standard Time. Ilan Sobel, CEO of BHSC, will host the event and provide an update on the significant progress the Company is making on executing on its previously announced Growth Strategy, shared publicly in early August. The CEO will be available for a question and answer session following the presentation. Furthermore, the Company is pleased to share that Key partner executives have been invited and will participate in the live video teleconference.
Click the following link to view the Zoom Conference Call information: BHSC: Zoom Video Conference
“On August 5th, 2020, we unveiled the Company’s growth strategy and the route to market for both our Superfruit Nutraceutical and Cannabis verticals, showing the importance of deploying a combined B2B and B2C approach. Since last June, the Company raised an aggregate gross proceed of $4,348,712.40, amidst a challenging macro-economic environment, demonstrating that investors have realized that the combination of BHSC’s unique patented BioFarming technology and management capabilities provide for a good investment opportunity. The majority of the proceeds will support our commitment to accelerate Vinia®’s marketing program and to invest in the required Capital Equipment for our new 20 Ton BioFarming manufacturing facility and for general corporate purposes. I have promised to BHSC’s Shareholders that our team will work relentlessly to achieve our growth strategy. I am eager to have the opportunity to share the significant progress we are making to execute this growth strategy during our Zoom Conference Call, and demonstrate that we are getting much closer to leveraging our proprietary patented BioFarming Platform Technology to source Revenue growth from targeting the sizeable and growing Nutraceutical and Cannabis Markets.” Commented Ilan Sobel.
The company’s email database will receive an invitation to the conference call, and all interested investors are welcomed to contact firstname.lastname@example.org to receive an invitation link and reminders. The live call has a maximum 100 concurrent attendees.
About BioHarvest Sciences Inc.
Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent protected Biofarming technology. It is the first and only industrial large-scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself. The technology has been already validated by Vinia™, the red grapes cells functional food/dietary supplement produced and sold by BioHarvest. By adapting this technology to the Cannabis plant, and building adequate cells production capacity, BioHarvest Sciences Inc.‘s objective is to become the leading supplier of Cannabis for both the medicinal and recreational legal use. See the following hyperlink for a visual description of our Biofarming technology: BHSC’s Biofarming Technology
BioHarvest Sciences Inc.
Chief Executive Officer
For further information, please contact:
Dave Ryan, VP Investor Relations & Director
Phone: 1 (604) 622-1186
Forward-Looking Statements Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are no guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.
Neither Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/63771
News Provided by Newsfile via QuoteMedia
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact email@example.com, or